The second most upregulated immune pathway in the responder tumor is 'regulation of innate immune response to cytosolic DNA', which corresponds to the concomitantly upregulated 'stimulator of interferon gene (STING)-mediated induction of host immune responses' pathway also dealing with the modulation of immune responses by cytosolic DNA. The gene discussed is STING1; the disease is neoplasm.